Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

Market Cap	4.43B
Revenue (ttm)	826.71M
Net Income (ttm)	-511.60M
Shares Out	193.20M
EPS (ttm)	-2.60
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	336,874
Average Volume	4,073,220
Open	23.08
Previous Close	22.36
Day's Range	22.77 - 23.09
52-Week Range	21.14 - 41.49
Beta	1.68
RSI	34.30
Earnings Date	Apr 30, 2025

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. The company offers IFA solutions, digital test, oral fluid test, and covid-19 test products; and immunological diagnosis product, such as hair drug test kit, monkeypox, saliva drug test, urine multi-drug test, urine single-drug test, rapid test, digital pregnancy test, male-fertility test, menopause test, and other test products. It also provides molecular diagnosis products, including nucleic acid extraction systems, real ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,231
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688298

Financial Performance

In 2024, SHA:688298's revenue was 826.71 million, an increase of 0.80% compared to the previous year's 820.16 million. Losses were -511.60 million, 28.7% more than in 2023.